Early Haemodynamic Optimization Using Preload Dependence During Septic Shock = EHOSS-1 (EHOSS-1)
Primary Purpose
Septic Shock
Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
FLUID MANAGEMENT GUIDED WITH PRELOAD-DEPENDENCE PARAMETERS (VOLUVEN ®)
STANDARD-GUIDED FLUID MANAGEMENT (VOLUVEN ®)
Sponsored by
About this trial
This is an interventional treatment trial for Septic Shock focused on measuring Septic shock, Randomized controlled trial, Preload dependence, Pulmonary thermodilution
Eligibility Criteria
Inclusion Criteria:
- age over 18 years
- and fulfilment of two of four criteria for the systemic inflammatory response syndrome
- and systolic blood pressure no higher than 90 mm Hg (after a crystalloid-fluid challenge of 25 ml per kilogram of body weight over a 30-minute period)
- and documented or suspected infection
Exclusion Criteria:
- delay between first observation of hypotension and inclusion above 12 hours
- pregnancy
- acute coronary syndrome
- acute cerebral vascular event (< 1 month),
- contraindication to central venous catheterization in the superior vena cava territory
- contraindication to femoral arterial catheterization
- active haemorrhage
- burn injury
- trauma
- requirement for immediate surgery (< 6 hours)
- acute pulmonary oedema of cardiogenic origin
- do-not-resuscitate status, or advanced directives restricting implementation of the protocol.
- Informed consent not obtained from the patient or surrogates
- Patient already included in another therapeutic trial
- patient previously included in the same therapeutic trial
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
PRELOAD DEPENDENCE
CONTROL
Arm Description
in this arm, fluid loading is administered with an algorithm using preload dependence indexes (variation in cardiac output in response to passive leg raising).
Outcomes
Primary Outcome Measures
Time to septic shock resolution
shock resolution is defined by vasopressor weaning
Secondary Outcome Measures
mortality
Ventilator free days
number of days with hyperlactactatemia
number of days with pulmonary edema
assessed by transpulmonary thermodilution
Full Information
NCT ID
NCT01972828
First Posted
October 11, 2013
Last Updated
October 30, 2013
Sponsor
Hospices Civils de Lyon
1. Study Identification
Unique Protocol Identification Number
NCT01972828
Brief Title
Early Haemodynamic Optimization Using Preload Dependence During Septic Shock = EHOSS-1
Acronym
EHOSS-1
Official Title
Effect of Haemodynamic Optimization Using Preload Dependence Indexes and Pulmonary Thermodilution on Cardiovascular Failure Duration During Septic Shock: a Randomized Study
Study Type
Interventional
2. Study Status
Record Verification Date
October 2013
Overall Recruitment Status
Completed
Study Start Date
July 2007 (undefined)
Primary Completion Date
August 2013 (Actual)
Study Completion Date
undefined (undefined)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Hospices Civils de Lyon
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Haemodynamic optimization is of paramount importance in septic shock, but is really consensual and standardized during the first 6 hours of treatment. Haemodynamic treatment including fluid loading management, vasoactive treatment and oxygen transport optimization is mainly based on expert recommendations or non-randomized trials. Recently, preload dependence indexes such as pulse pressure variation have been shown to be more accurate to predict fluid responsiveness than static indexes such as filling pressures. However, whether using preload dependence indexes changes septic shock prognostic remains to date unknown. The aim of this non-blinded randomized controlled trial is to assess whether haemodynamic optimization using preload dependence indexes and pulmonary thermodilution 1. reduces septic shock duration assessed by administration duration of vasoactive treatment (primary end point), 2. reduces regional hypoperfusion assessed by arterial lactate, 3. reduces lung hydrostatic oedema linked to excessive fluid loading (assessed by PaO2/FIO2 ratio and extravascular lung water). 4. reduces organ dysfunction (assessed by the SOFA score), ICU stay and 7 and 28 day mortality Control group is managed with an algorithm using filling pressures to drive haemodynamic treatment.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Septic Shock
Keywords
Septic shock, Randomized controlled trial, Preload dependence, Pulmonary thermodilution
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
61 (Actual)
8. Arms, Groups, and Interventions
Arm Title
PRELOAD DEPENDENCE
Arm Type
Experimental
Arm Description
in this arm, fluid loading is administered with an algorithm using preload dependence indexes (variation in cardiac output in response to passive leg raising).
Arm Title
CONTROL
Arm Type
Active Comparator
Intervention Type
Drug
Intervention Name(s)
FLUID MANAGEMENT GUIDED WITH PRELOAD-DEPENDENCE PARAMETERS (VOLUVEN ®)
Other Intervention Name(s)
Drug : ringer lactate, 0.9% saline, VOLUVEN ®, Procedure: haemodynamic algorithm (see below)
Intervention Description
in this arm, fluid loading is administered with an algorithm using preload dependence indexes. This algorithm is used every hour during the first 6 hours after inclusion, then every 4 hours until vasopressor weaning, and whenever mean arterial pressure fell below 65 mm Hg. Fluid loading is performed with cristalloids or colloids at the discretion of the attending physician.
Intervention Type
Drug
Intervention Name(s)
STANDARD-GUIDED FLUID MANAGEMENT (VOLUVEN ®)
Other Intervention Name(s)
Drug : ringer lactate, 0.9% saline, VOLUVEN ®, Procedure: haemodynamic algorithm (see below)
Intervention Description
in this arm, fluid loading is administered with an algorithm using central venous pressure. This algorithm is used every hour during the first 6 hours after inclusion, then every 4 hours until vasopressor weaning, and whenever mean arterial pressure fell below 65 mm Hg. Fluid loading is performed with cristalloids or colloids at the discretion of the attending physician.
Primary Outcome Measure Information:
Title
Time to septic shock resolution
Description
shock resolution is defined by vasopressor weaning
Time Frame
28 days
Secondary Outcome Measure Information:
Title
mortality
Time Frame
28 days
Title
Ventilator free days
Time Frame
28 days
Title
number of days with hyperlactactatemia
Time Frame
28 days
Title
number of days with pulmonary edema
Description
assessed by transpulmonary thermodilution
Time Frame
28 jours
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
age over 18 years
and fulfilment of two of four criteria for the systemic inflammatory response syndrome
and systolic blood pressure no higher than 90 mm Hg (after a crystalloid-fluid challenge of 25 ml per kilogram of body weight over a 30-minute period)
and documented or suspected infection
Exclusion Criteria:
delay between first observation of hypotension and inclusion above 12 hours
pregnancy
acute coronary syndrome
acute cerebral vascular event (< 1 month),
contraindication to central venous catheterization in the superior vena cava territory
contraindication to femoral arterial catheterization
active haemorrhage
burn injury
trauma
requirement for immediate surgery (< 6 hours)
acute pulmonary oedema of cardiogenic origin
do-not-resuscitate status, or advanced directives restricting implementation of the protocol.
Informed consent not obtained from the patient or surrogates
Patient already included in another therapeutic trial
patient previously included in the same therapeutic trial
12. IPD Sharing Statement
Citations:
PubMed Identifier
25572383
Citation
Richard JC, Bayle F, Bourdin G, Leray V, Debord S, Delannoy B, Stoian AC, Wallet F, Yonis H, Guerin C. Preload dependence indices to titrate volume expansion during septic shock: a randomized controlled trial. Crit Care. 2015 Jan 8;19(1):5. doi: 10.1186/s13054-014-0734-3.
Results Reference
derived
Learn more about this trial
Early Haemodynamic Optimization Using Preload Dependence During Septic Shock = EHOSS-1
We'll reach out to this number within 24 hrs